IRCT2017050333789N1
Completed
Phase 2
Assessment of efficacy of weekly paclitaxel as a neoadjuvant chemotherapy in advanced ovarian cancers
Taleghani Hospital- Shahid Beheshti University of Medical Sciences0 sites14 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Advanced Ovarian Cancer.
- Sponsor
- Taleghani Hospital- Shahid Beheshti University of Medical Sciences
- Enrollment
- 14
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age over 18yr; Ovarian cancer confirmed by biopsy and pathology; Advanced disease confirmed by CT scan (Stage III or IV); No previous history of chemotherapy; Good liver and lung functional status; No candidate for primary surgery due to underlying disease; Full access to patients medical documents; Patient satisfaction for study participation
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
ow dose cancer drugs for advanced stomach cancerHealth Condition 1: C169- Malignant neoplasm of stomach, unspecifiedCTRI/2022/11/047033JIPMER PONDICHERRY
Recruiting
Phase 2
A study of low intensity chemotherapy in relapsed and refractory lymphoma patientsHealth Condition 1: C817- Other Hodgkin lymphomaHealth Condition 2: C858- Other specified types of non-Hodgkin lymphomaCTRI/2020/08/026992Jawaharlal Institute Post Graduate Medical Education and Research
Completed
Phase 2
A phase II study of weekly paclitaxel for advanced or recurrent esophageal canceradvanced or reccurent esophageal cancerJPRN-UMIN000009807Medical Oncology, Hirosaki University Graduate School of Medicine30
Recruiting
Phase 2
Improving Performance status of Advanced lung cancer patients with ChemotherapyHealth Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lungCTRI/2020/01/022617All India Institute of Medical Sciences
Completed
Phase 2
Comparison of efficacy of Paclitaxel with Cisplatin when given weekly along with radiation in patients suffering from Head and Neck cancers.CTRI/2017/09/009864Jawaharlal Institute of Post Graduate Medical Education and Research54